AllovirInc Short Long Term Debt Total vs Other Assets Analysis
ALVR Stock | USD 0.77 0.01 1.28% |
AllovirInc financial indicator trend analysis is way more than just evaluating AllovirInc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AllovirInc is a good investment. Please check the relationship between AllovirInc Short Long Term Debt Total and its Other Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AllovirInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. To learn how to invest in AllovirInc Stock, please use our How to Invest in AllovirInc guide.
Short Long Term Debt Total vs Other Assets
Short Long Term Debt Total vs Other Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AllovirInc Short Long Term Debt Total account and Other Assets. At this time, the significance of the direction appears to have weak relationship.
The correlation between AllovirInc's Short Long Term Debt Total and Other Assets is 0.39. Overlapping area represents the amount of variation of Short Long Term Debt Total that can explain the historical movement of Other Assets in the same time period over historical financial statements of AllovirInc, assuming nothing else is changed. The correlation between historical values of AllovirInc's Short Long Term Debt Total and Other Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt Total of AllovirInc are associated (or correlated) with its Other Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Assets has no effect on the direction of Short Long Term Debt Total i.e., AllovirInc's Short Long Term Debt Total and Other Assets go up and down completely randomly.
Correlation Coefficient | 0.39 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Short Long Term Debt Total
Other Assets
Most indicators from AllovirInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AllovirInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AllovirInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. To learn how to invest in AllovirInc Stock, please use our How to Invest in AllovirInc guide.At this time, AllovirInc's Issuance Of Capital Stock is relatively stable compared to the past year. As of 05/21/2024, Sales General And Administrative To Revenue is likely to grow to 60.81, while Selling General Administrative is likely to drop slightly above 33.9 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 1.3M | 1.9M | 5.3M | 5.5M | Net Interest Income | 1.3M | 1.9M | 5.3M | 5.5M |
AllovirInc fundamental ratios Correlations
Click cells to compare fundamentals
AllovirInc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
AllovirInc fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 139.4M | 370.8M | 286.6M | 277.1M | 190.8M | 236.5M | |
Other Current Liab | 5.4M | 8.1M | 22.9M | 14.2M | 10.8M | 11.4M | |
Total Current Liabilities | 9.1M | 12.3M | 37.9M | 24.3M | 28.4M | 21.2M | |
Total Stockholder Equity | (51.5M) | 353.1M | 225.3M | 224.5M | 145.8M | 158.9M | |
Net Tangible Assets | (51.5M) | 353.1M | 225.3M | 224.5M | 258.2M | 158.6M | |
Net Debt | (49.3M) | (114.0M) | (171.6M) | (70.7M) | (62.7M) | (65.8M) | |
Retained Earnings | (55.3M) | (125.1M) | (297.1M) | (465.8M) | (656.2M) | (623.4M) | |
Accounts Payable | 630K | 963K | 8.4M | 3.0M | 6.8M | 3.6M | |
Cash | 61.1M | 122.7M | 201.7M | 106.1M | 90.1M | 110.7M | |
Non Current Assets Total | 12.1M | 9.5M | 33.2M | 34.0M | 3.2M | 3.0M | |
Cash And Short Term Investments | 126.1M | 356.3M | 248.1M | 233.8M | 183.9M | 214.6M | |
Net Receivables | 560K | 450K | 50K | 157K | 206K | 230K | |
Common Stock Shares Outstanding | 65.1M | 26.9M | 62.8M | 76.7M | 104.1M | 68.3M | |
Short Term Investments | 65.0M | 233.7M | 46.5M | 127.7M | 93.8M | 103.9M | |
Liabilities And Stockholders Equity | 139.4M | 370.8M | 286.6M | 277.1M | 190.8M | 236.5M | |
Non Current Liabilities Total | 181.8M | 5.5M | 23.5M | 28.2M | 16.6M | 15.8M | |
Capital Lease Obligations | 11.8M | 8.7M | 30.1M | 35.4M | 27.4M | 20.8M | |
Other Current Assets | 676K | 5.0M | 5.2M | 9.3M | 3.5M | 4.3M | |
Other Stockholder Equity | (169.4M) | 107.5M | 522.5M | 690.8M | 802.0M | 842.1M | |
Total Liab | 190.9M | 17.8M | 61.3M | 52.6M | 45.0M | 56.5M | |
Net Invested Capital | (51.5M) | 353.1M | 225.3M | 224.5M | 145.8M | 158.9M | |
Total Current Assets | 127.3M | 361.3M | 253.3M | 243.1M | 187.6M | 219.6M | |
Net Working Capital | 118.2M | 349.0M | 215.5M | 218.7M | 159.3M | 198.4M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in AllovirInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. To learn how to invest in AllovirInc Stock, please use our How to Invest in AllovirInc guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for AllovirInc Stock analysis
When running AllovirInc's price analysis, check to measure AllovirInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AllovirInc is operating at the current time. Most of AllovirInc's value examination focuses on studying past and present price action to predict the probability of AllovirInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AllovirInc's price. Additionally, you may evaluate how the addition of AllovirInc to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |
Is AllovirInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AllovirInc. If investors know AllovirInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AllovirInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.65) | Return On Assets (0.52) | Return On Equity (1.14) |
The market value of AllovirInc is measured differently than its book value, which is the value of AllovirInc that is recorded on the company's balance sheet. Investors also form their own opinion of AllovirInc's value that differs from its market value or its book value, called intrinsic value, which is AllovirInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AllovirInc's market value can be influenced by many factors that don't directly affect AllovirInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AllovirInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if AllovirInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AllovirInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.